Geroscience in the Age of COVID-19

The data on COVID-19 is clear on at least one point: Older adults are most vulnerable to hospitalization, disability and death following infection with the novel coronavirus. Therefore, therapeutically addressing degenerative aging processes as the main risk factors appears promising for tackling the present crisis and is expected to be relevant when tackling future infections, epidemics and pandemics. Therefore, utilizing a geroscience approach, targeting aging processes to prevent multimorbidity, via initiating broad clinical trials of potential geroprotective therapies, is recommended.

• Publication year

  2020

• Venue

  Aging and Disease

• Publication date

  2020-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.14336/AD.2020.0629PMID 32765937PMCID 7390533
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

  2020cited by this paper
• Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis

  2020cited by this paper
• Innate and Adaptive Immunity in Aging and Longevity: The Foundation of Resilience

  2020cited by this paper
• Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19

  2020cited by this paper
• Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis

  2020cited by this paper
• Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

  2020cited by this paper
• Benefits of Metformin in Attenuating the Hallmarks of Aging.

  2020cited by this paper
• Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

  2020cited by this paper
• Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

  2020cited by this paper
• Measuring biological aging in humans: A quest

  2019cited by this paper
• Rapamycin for longevity: opinion article

  2019cited by this paper
• Aging Health and R&D for Healthy Longevity Must Be Included into the WHO Work Program

  2018cited by this paper
• A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects

  2018cited by this paper
• TORC1 inhibition enhances immune function and reduces infections in the elderly

  2018cited by this paper
• Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy

  2017cited by this paper
• Geroscience and the trans-NIH Geroscience Interest Group, GSIG

  2017cited by this paper
• Metformin: historical overview

  2017cited by this paper
• Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes.

  2017cited by this paper
• Strategies and Challenges in Clinical Trials Targeting Human Aging

  2016cited by this paper
• Metformin as a Tool to Target Aging.

  2016cited by this paper
• Quantification of biological aging in young adults

  2015cited by this paper
• Interventions to Slow Aging in Humans: Are We Ready?

  2015cited by this paper
• The Critical Need to Promote Research of Aging and Aging-related Diseases to Improve Health and Longevity of the Elderly Population.

  2015cited by this paper
• Healthy aging: The ultimate preventative medicine

  2015cited by this paper
• Geroscience: linking aging to chronic disease.

  2014cited by this paper
• mTOR inhibition improves immune function in the elderly

  2014cited by this paper
• The hallmarks of aging.

  2013cited by this paper
• mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells

  2009cited by this paper
• Immunosenescence: emerging challenges for an ageing population

  2007cited by this paper
• Extending life: scientific prospects and political obstacles.

  2002cited by this paper

• Emerging uncertainty on the anti-aging potential of metformin.

  2025cites this paper
• Exploring Age-Related Influences on COVID-19 Severity and Therapeutic Approaches for Older Patients

  2025cites this paper
• Gender difference in the association between volunteering and health-related quality of life among hearing-impaired older adults in China

  2024cites this paper
• Negative effects of lifespan extending intervention on resilience in mice

  2024cites this paper
• From Sanitation Science to Geroscience: Public Health Must Transcend ‘Folkbiology’

  2023cites this paper
• New Frailty Index Approach Predicts COVID-19 Mortality Risk

  2023cites this paper
• Longevity Science and Women’s Health and Wellbeing

  2023cites this paper
• Advanced pathological ageing should be represented in the ICD.

  2022cites this paper
• A vicious cycle of health (in)equity: Migrant inclusion in light of COVID-19

  2022cites this paper
• SARS-CoV-2 Morbidity in the CNS and the Aged Brain Specific Vulnerability

  2022cites this paper
• The Effect of Dual Sensory Impairment and Multimorbidity Patterns on Functional Impairment: A Longitudinal Cohort of Middle-Aged and Older Adults in China

  2022cites this paper
• The interplay of post-acute COVID-19 syndrome and aging: a biological, clinical and public health approach

  2022cites this paper
• Aging, Equality and the Human Healthspan

  2022cites this paper
• Gerociencia en tiempos de pandemia global por COVID-19

  2021cites this paper
• Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS

  2021cites this paper
• Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms

  2021cites this paper
• The COVID-19 Pandemic, Biogerontology and the Ageing of Humanity.

  2021cites this paper
• How should we theorize about justice in the genomic era?

  2021cites this paper
• The aging lung: Physiology, disease, and immunity

  2021cites this paper
• Importance of population-based longitudinal studies to understanding the impact of COVID-19

  2021cites this paper
• Modify alpha value of EMA method and brown method: A data forecasting comparison of COVID-19

  2021cites this paper
• All Nations Must Prioritize the COVID-19 Vaccination Program for Elderly Adults Urgently

  2021cites this paper
• Geroscience

  2020cites this paper
• COVID-19: A Challenge to Physiology of Aging

  2020cites this paper
• A Potential Role for Photobiomodulation Therapy in Disease Treatment and Prevention in the Era of COVID-19

  2020cites this paper
• The geroscience agenda: Toxic stress, hormetic stress, and the rate of aging

  2020cites this paper